 Samuel Gubbels
Concepts (362)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implants | 8 | 2023 | 91 | 3.190 |
Why?
| | Neuroma, Acoustic | 9 | 2024 | 55 | 3.040 |
Why?
| | Cochlear Implantation | 8 | 2023 | 76 | 2.750 |
Why?
| | Cochlea | 10 | 2024 | 71 | 2.650 |
Why?
| | Hearing Loss | 8 | 2025 | 234 | 2.190 |
Why?
| | Speech Perception | 6 | 2024 | 88 | 2.040 |
Why?
| | Hearing | 9 | 2025 | 125 | 1.690 |
Why?
| | Audiometry, Pure-Tone | 5 | 2024 | 32 | 1.450 |
Why?
| | Semicircular Canals | 4 | 2021 | 33 | 1.370 |
Why?
| | Ear, Inner | 6 | 2024 | 52 | 1.170 |
Why?
| | Nestin | 3 | 2024 | 20 | 1.170 |
Why?
| | Otitis Media | 7 | 2022 | 168 | 1.030 |
Why?
| | Deafness | 5 | 2023 | 79 | 1.010 |
Why?
| | Radiosurgery | 3 | 2019 | 389 | 0.970 |
Why?
| | Otitis Media with Effusion | 3 | 2014 | 20 | 0.880 |
Why?
| | Hair Cells, Auditory | 5 | 2024 | 39 | 0.840 |
Why?
| | Vestibule, Labyrinth | 2 | 2024 | 90 | 0.840 |
Why?
| | Nasopharyngeal Diseases | 2 | 2014 | 5 | 0.820 |
Why?
| | Gentamicins | 1 | 2023 | 51 | 0.780 |
Why?
| | Unnecessary Procedures | 2 | 2014 | 54 | 0.780 |
Why?
| | Labyrinth Diseases | 3 | 2020 | 8 | 0.720 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 26 | 0.700 |
Why?
| | Endoscopy | 3 | 2020 | 327 | 0.700 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2021 | 14 | 0.690 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 80 | 0.650 |
Why?
| | Otolaryngologists | 1 | 2020 | 14 | 0.650 |
Why?
| | Ear Neoplasms | 2 | 2024 | 10 | 0.640 |
Why?
| | Temporal Bone | 6 | 2024 | 43 | 0.610 |
Why?
| | Paraganglioma | 1 | 2020 | 53 | 0.610 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 31 | 0.600 |
Why?
| | Tinnitus | 3 | 2018 | 60 | 0.600 |
Why?
| | Eustachian Tube | 1 | 2018 | 8 | 0.580 |
Why?
| | Hearing Loss, Sensorineural | 6 | 2022 | 68 | 0.570 |
Why?
| | Meningioma | 1 | 2019 | 89 | 0.570 |
Why?
| | Vertigo | 3 | 2023 | 53 | 0.570 |
Why?
| | Meningeal Neoplasms | 1 | 2019 | 97 | 0.560 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2018 | 82 | 0.540 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3734 | 0.530 |
Why?
| | Radiation Injuries | 1 | 2018 | 148 | 0.520 |
Why?
| | Hearing Aids | 2 | 2016 | 85 | 0.520 |
Why?
| | Physicians' Offices | 1 | 2016 | 18 | 0.510 |
Why?
| | Surgical Flaps | 2 | 2016 | 144 | 0.490 |
Why?
| | Humans | 63 | 2025 | 141284 | 0.480 |
Why?
| | Membrane Proteins | 2 | 2020 | 1144 | 0.480 |
Why?
| | Hearing Tests | 3 | 2025 | 49 | 0.480 |
Why?
| | Suture Anchors | 1 | 2016 | 34 | 0.480 |
Why?
| | Skin Transplantation | 1 | 2016 | 84 | 0.460 |
Why?
| | Sex Characteristics | 1 | 2021 | 783 | 0.460 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 557 | 0.450 |
Why?
| | Benign Paroxysmal Positional Vertigo | 3 | 2021 | 6 | 0.440 |
Why?
| | Device Removal | 1 | 2016 | 141 | 0.440 |
Why?
| | Cranial Fossa, Middle | 2 | 2020 | 17 | 0.430 |
Why?
| | Cell Differentiation | 2 | 2021 | 1983 | 0.430 |
Why?
| | Bacteriological Techniques | 1 | 2014 | 66 | 0.430 |
Why?
| | Blood | 1 | 2014 | 110 | 0.430 |
Why?
| | Hyperacusis | 1 | 2014 | 8 | 0.430 |
Why?
| | Cholesteatoma | 1 | 2014 | 10 | 0.420 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2765 | 0.400 |
Why?
| | Jugular Veins | 1 | 2013 | 42 | 0.390 |
Why?
| | Glomus Jugulare Tumor | 1 | 2012 | 5 | 0.390 |
Why?
| | Polyvinyls | 1 | 2012 | 20 | 0.380 |
Why?
| | Carotid Body Tumor | 1 | 2012 | 5 | 0.380 |
Why?
| | Otologic Surgical Procedures | 5 | 2024 | 21 | 0.380 |
Why?
| | Patient Selection | 1 | 2016 | 685 | 0.380 |
Why?
| | Influenza B virus | 1 | 2012 | 44 | 0.380 |
Why?
| | Carotid Artery, Internal | 1 | 2012 | 44 | 0.380 |
Why?
| | Cranial Nerve Diseases | 1 | 2012 | 42 | 0.370 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2012 | 19 | 0.370 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 768 | 0.370 |
Why?
| | Bacteremia | 1 | 2014 | 218 | 0.370 |
Why?
| | Mutation | 2 | 2020 | 4006 | 0.360 |
Why?
| | Stapes Surgery | 2 | 2023 | 10 | 0.360 |
Why?
| | Denmark | 5 | 2016 | 47 | 0.350 |
Why?
| | Influenza A virus | 1 | 2012 | 110 | 0.350 |
Why?
| | Melanoma | 1 | 2018 | 786 | 0.350 |
Why?
| | Middle Aged | 20 | 2024 | 34658 | 0.340 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 605 | 0.340 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 153 | 0.330 |
Why?
| | Retrospective Studies | 15 | 2024 | 16447 | 0.330 |
Why?
| | Artifacts | 2 | 2023 | 133 | 0.330 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.320 |
Why?
| | Female | 26 | 2024 | 75814 | 0.320 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 242 | 0.320 |
Why?
| | Aging | 2 | 2021 | 1919 | 0.310 |
Why?
| | Male | 29 | 2024 | 70140 | 0.310 |
Why?
| | Laser Therapy | 2 | 2023 | 128 | 0.310 |
Why?
| | Adult | 22 | 2025 | 39319 | 0.310 |
Why?
| | Transfection | 2 | 2009 | 932 | 0.310 |
Why?
| | Genetic Therapy | 5 | 2020 | 315 | 0.300 |
Why?
| | Animals | 17 | 2024 | 37328 | 0.280 |
Why?
| | Mice | 11 | 2024 | 17969 | 0.280 |
Why?
| | Cerebrospinal Fluid Otorrhea | 1 | 2007 | 6 | 0.280 |
Why?
| | Bacteria | 1 | 2014 | 872 | 0.280 |
Why?
| | Encephalocele | 1 | 2007 | 12 | 0.270 |
Why?
| | Nasopharynx | 2 | 2022 | 73 | 0.270 |
Why?
| | Uterus | 1 | 2008 | 221 | 0.260 |
Why?
| | Urinary Tract Infections | 2 | 2022 | 195 | 0.260 |
Why?
| | Cross Infection | 2 | 2022 | 259 | 0.250 |
Why?
| | Aged | 14 | 2024 | 24836 | 0.250 |
Why?
| | Tracheal Diseases | 1 | 2006 | 15 | 0.250 |
Why?
| | Intensive Care Units | 1 | 2012 | 868 | 0.250 |
Why?
| | Bioprosthesis | 1 | 2006 | 39 | 0.240 |
Why?
| | Influenza, Human | 1 | 2012 | 630 | 0.240 |
Why?
| | Neurons | 1 | 2015 | 1611 | 0.240 |
Why?
| | Cholesteatoma, Middle Ear | 1 | 2024 | 3 | 0.220 |
Why?
| | Petrous Bone | 1 | 2024 | 8 | 0.220 |
Why?
| | Treatment Outcome | 10 | 2024 | 11216 | 0.220 |
Why?
| | Trachea | 1 | 2006 | 250 | 0.220 |
Why?
| | Airway Obstruction | 1 | 2006 | 166 | 0.210 |
Why?
| | Saccule and Utricle | 1 | 2024 | 13 | 0.210 |
Why?
| | Incidence | 5 | 2016 | 2809 | 0.210 |
Why?
| | Audiometry | 2 | 2014 | 32 | 0.200 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2003 | 17 | 0.200 |
Why?
| | Cadaver | 5 | 2023 | 305 | 0.200 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2003 | 46 | 0.200 |
Why?
| | Penicillins | 1 | 2023 | 59 | 0.200 |
Why?
| | Meniere Disease | 1 | 2023 | 35 | 0.190 |
Why?
| | Neurofibromatosis 2 | 1 | 2022 | 4 | 0.190 |
Why?
| | Synapses | 2 | 2021 | 428 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 41 | 0.180 |
Why?
| | Migraine Disorders | 1 | 2023 | 106 | 0.180 |
Why?
| | Microsurgery | 2 | 2020 | 77 | 0.180 |
Why?
| | Labyrinthitis | 1 | 2021 | 2 | 0.170 |
Why?
| | Otolithic Membrane | 1 | 2021 | 6 | 0.170 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 186 | 0.170 |
Why?
| | Neurons, Efferent | 1 | 2021 | 9 | 0.170 |
Why?
| | Vestibular Nerve | 1 | 2021 | 19 | 0.170 |
Why?
| | Aged, 80 and over | 6 | 2016 | 7948 | 0.170 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 630 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 32 | 0.160 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2165 | 0.160 |
Why?
| | Noise | 1 | 2021 | 68 | 0.160 |
Why?
| | Vestibular Diseases | 1 | 2021 | 53 | 0.160 |
Why?
| | Scoliosis | 1 | 2023 | 220 | 0.160 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 614 | 0.160 |
Why?
| | Ear, Middle | 4 | 2022 | 82 | 0.160 |
Why?
| | Hypersensitivity | 1 | 2023 | 257 | 0.160 |
Why?
| | Magnets | 1 | 2019 | 20 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
| | Microbiota | 3 | 2022 | 753 | 0.150 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 7 | 0.140 |
Why?
| | Hearing Loss, Bilateral | 1 | 2018 | 11 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 337 | 0.140 |
Why?
| | Surgical Equipment | 1 | 2017 | 10 | 0.130 |
Why?
| | Mucous Membrane | 1 | 2018 | 127 | 0.130 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2017 | 15 | 0.130 |
Why?
| | Neurotology | 1 | 2017 | 5 | 0.130 |
Why?
| | Hospitals | 3 | 2022 | 688 | 0.130 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 125 | 0.130 |
Why?
| | Genetic Testing | 1 | 2020 | 462 | 0.130 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 403 | 0.130 |
Why?
| | Dissection | 1 | 2017 | 55 | 0.130 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5866 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 636 | 0.130 |
Why?
| | Regeneration | 1 | 2018 | 196 | 0.120 |
Why?
| | Patient Positioning | 1 | 2017 | 71 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 169 | 0.120 |
Why?
| | Infant | 7 | 2019 | 9820 | 0.120 |
Why?
| | Hearing Loss, Unilateral | 1 | 2016 | 5 | 0.120 |
Why?
| | Diagnosis, Differential | 5 | 2021 | 1491 | 0.120 |
Why?
| | Electrodes, Implanted | 1 | 2016 | 112 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 815 | 0.120 |
Why?
| | Organogenesis | 1 | 2016 | 61 | 0.120 |
Why?
| | Age Factors | 3 | 2012 | 3295 | 0.120 |
Why?
| | Automation | 1 | 2016 | 101 | 0.120 |
Why?
| | Scalp | 1 | 2016 | 35 | 0.120 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 67 | 0.120 |
Why?
| | Adolescent | 8 | 2023 | 22116 | 0.120 |
Why?
| | Child, Preschool | 7 | 2019 | 11511 | 0.120 |
Why?
| | Plant Lectins | 1 | 2015 | 8 | 0.110 |
Why?
| | Ifosfamide | 1 | 2015 | 38 | 0.110 |
Why?
| | Estrogen Antagonists | 1 | 2015 | 45 | 0.110 |
Why?
| | Durapatite | 2 | 2021 | 36 | 0.110 |
Why?
| | Child | 9 | 2023 | 22390 | 0.110 |
Why?
| | Ki-67 Antigen | 1 | 2015 | 111 | 0.110 |
Why?
| | Etoposide | 1 | 2015 | 163 | 0.110 |
Why?
| | Quality of Life | 3 | 2023 | 3024 | 0.110 |
Why?
| | Audiology | 1 | 2014 | 21 | 0.110 |
Why?
| | Educational Measurement | 1 | 2017 | 318 | 0.110 |
Why?
| | Tamoxifen | 1 | 2015 | 203 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 506 | 0.110 |
Why?
| | Luminescent Proteins | 1 | 2015 | 182 | 0.100 |
Why?
| | Animals, Newborn | 1 | 2016 | 866 | 0.100 |
Why?
| | Methotrexate | 1 | 2015 | 255 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 993 | 0.100 |
Why?
| | Head Injuries, Closed | 2 | 2014 | 49 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2017 | 3345 | 0.100 |
Why?
| | Eye Movement Measurements | 1 | 2013 | 14 | 0.100 |
Why?
| | Vestibular Evoked Myogenic Potentials | 1 | 2013 | 17 | 0.100 |
Why?
| | Young Adult | 6 | 2019 | 13727 | 0.100 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2012 | 4 | 0.100 |
Why?
| | Central Nervous System Cysts | 1 | 2012 | 13 | 0.100 |
Why?
| | Oral Surgical Procedures | 2 | 2011 | 5 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1866 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2010 | 5222 | 0.090 |
Why?
| | Salmonella Food Poisoning | 1 | 2012 | 12 | 0.090 |
Why?
| | Disease Notification | 1 | 2012 | 16 | 0.090 |
Why?
| | Meat Products | 1 | 2012 | 27 | 0.090 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 412 | 0.090 |
Why?
| | Food Contamination | 1 | 2012 | 54 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1761 | 0.090 |
Why?
| | Seasons | 1 | 2014 | 547 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 684 | 0.090 |
Why?
| | Laryngoscopy | 1 | 2013 | 121 | 0.090 |
Why?
| | Phenotype | 1 | 2020 | 3172 | 0.090 |
Why?
| | Disease Progression | 1 | 2019 | 2808 | 0.090 |
Why?
| | Labyrinth Supporting Cells | 1 | 2011 | 3 | 0.090 |
Why?
| | Organ of Corti | 1 | 2011 | 14 | 0.090 |
Why?
| | Radiography | 1 | 2014 | 845 | 0.090 |
Why?
| | Viral Tropism | 1 | 2011 | 33 | 0.090 |
Why?
| | Age Distribution | 1 | 2012 | 396 | 0.090 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2011 | 9 | 0.090 |
Why?
| | Sex Distribution | 1 | 2012 | 381 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 2069 | 0.090 |
Why?
| | Foodborne Diseases | 1 | 2012 | 60 | 0.090 |
Why?
| | Skull Base | 2 | 2021 | 55 | 0.080 |
Why?
| | Ear Canal | 1 | 2011 | 16 | 0.080 |
Why?
| | Ear Diseases | 1 | 2011 | 17 | 0.080 |
Why?
| | Ganglion Cysts | 1 | 2011 | 10 | 0.080 |
Why?
| | Lasers | 2 | 2023 | 129 | 0.080 |
Why?
| | Sex Factors | 2 | 2014 | 2055 | 0.080 |
Why?
| | Cranial Nerve Neoplasms | 1 | 2010 | 8 | 0.080 |
Why?
| | Zygoma | 1 | 2010 | 7 | 0.080 |
Why?
| | Neurosurgical Procedures | 1 | 2012 | 199 | 0.080 |
Why?
| | Dependovirus | 1 | 2011 | 76 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1973 | 0.080 |
Why?
| | Salmonella typhimurium | 1 | 2012 | 189 | 0.080 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 248 | 0.080 |
Why?
| | Adenoviridae | 1 | 2011 | 199 | 0.080 |
Why?
| | Cost of Illness | 1 | 2012 | 311 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 177 | 0.080 |
Why?
| | Abscess | 1 | 2010 | 77 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2600 | 0.080 |
Why?
| | Genetic Vectors | 1 | 2011 | 336 | 0.080 |
Why?
| | Maxilla | 1 | 2009 | 36 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 619 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 717 | 0.070 |
Why?
| | Clinical Competence | 1 | 2017 | 1210 | 0.070 |
Why?
| | Electroencephalography | 1 | 2012 | 522 | 0.070 |
Why?
| | Skull Fractures | 1 | 2009 | 38 | 0.070 |
Why?
| | Electroporation | 1 | 2009 | 39 | 0.070 |
Why?
| | Middle Ear Ventilation | 1 | 2008 | 15 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2016 | 2502 | 0.070 |
Why?
| | Comorbidity | 1 | 2014 | 1671 | 0.070 |
Why?
| | Disease Outbreaks | 1 | 2012 | 424 | 0.070 |
Why?
| | Electric Conductivity | 1 | 2008 | 85 | 0.070 |
Why?
| | Population Surveillance | 1 | 2012 | 481 | 0.070 |
Why?
| | Dyneins | 1 | 2008 | 34 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 565 | 0.070 |
Why?
| | Prospective Studies | 3 | 2012 | 7805 | 0.070 |
Why?
| | Swine | 2 | 2012 | 821 | 0.070 |
Why?
| | Myosins | 1 | 2008 | 137 | 0.070 |
Why?
| | Cleft Lip | 1 | 2008 | 65 | 0.070 |
Why?
| | Cleft Palate | 1 | 2008 | 81 | 0.070 |
Why?
| | Bone Cements | 1 | 2007 | 41 | 0.070 |
Why?
| | Chronic Disease | 1 | 2014 | 1807 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2008 | 4414 | 0.070 |
Why?
| | Craniotomy | 1 | 2007 | 78 | 0.070 |
Why?
| | Mechanotransduction, Cellular | 1 | 2008 | 116 | 0.070 |
Why?
| | Internship and Residency | 1 | 2017 | 1230 | 0.060 |
Why?
| | Tonsillar Neoplasms | 1 | 2005 | 10 | 0.060 |
Why?
| | Neck Dissection | 1 | 2005 | 18 | 0.060 |
Why?
| | Postoperative Care | 1 | 2007 | 280 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1791 | 0.060 |
Why?
| | Random Allocation | 1 | 2006 | 369 | 0.060 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2005 | 95 | 0.060 |
Why?
| | Neck | 1 | 2005 | 106 | 0.060 |
Why?
| | Prevalence | 1 | 2012 | 2795 | 0.060 |
Why?
| | Biomarkers | 1 | 2016 | 4180 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 157 | 0.060 |
Why?
| | Rabbits | 1 | 2006 | 664 | 0.060 |
Why?
| | Biopsy | 2 | 2011 | 1073 | 0.060 |
Why?
| | Neurilemmoma | 1 | 2024 | 24 | 0.050 |
Why?
| | Models, Animal | 1 | 2006 | 391 | 0.050 |
Why?
| | Safety | 1 | 2006 | 356 | 0.050 |
Why?
| | Hearing Disorders | 1 | 2003 | 10 | 0.050 |
Why?
| | Biocompatible Materials | 1 | 2007 | 431 | 0.050 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 35 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2012 | 3577 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2014 | 6270 | 0.050 |
Why?
| | Algorithms | 3 | 2017 | 1764 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2024 | 244 | 0.050 |
Why?
| | Eye Diseases | 1 | 2003 | 93 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2021 | 2831 | 0.050 |
Why?
| | Hospitalization | 1 | 2012 | 2264 | 0.050 |
Why?
| | Hydroxyapatites | 1 | 2021 | 16 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 156 | 0.040 |
Why?
| | Esthetics | 1 | 2021 | 47 | 0.040 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2021 | 2 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.040 |
Why?
| | Lithiasis | 1 | 2021 | 3 | 0.040 |
Why?
| | Recurrence | 1 | 2024 | 1108 | 0.040 |
Why?
| | Facial Nerve | 1 | 2021 | 39 | 0.040 |
Why?
| | Auditory Threshold | 2 | 2011 | 47 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 641 | 0.040 |
Why?
| | Scala Tympani | 1 | 2020 | 5 | 0.040 |
Why?
| | Nose | 1 | 2020 | 65 | 0.040 |
Why?
| | Infection Control | 1 | 2022 | 171 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2003 | 501 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2021 | 215 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 52 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 542 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 77 | 0.040 |
Why?
| | Finland | 1 | 2019 | 81 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 5948 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 246 | 0.040 |
Why?
| | Pregnancy | 2 | 2009 | 7035 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 179 | 0.040 |
Why?
| | Pharmacokinetics | 1 | 2018 | 31 | 0.040 |
Why?
| | Incus | 1 | 2017 | 6 | 0.030 |
Why?
| | Ear Ossicles | 1 | 2017 | 11 | 0.030 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 96 | 0.030 |
Why?
| | Stapes | 1 | 2017 | 25 | 0.030 |
Why?
| | Exome | 1 | 2018 | 235 | 0.030 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 72 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 444 | 0.030 |
Why?
| | Pressure | 1 | 2017 | 232 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1037 | 0.030 |
Why?
| | Forecasting | 1 | 2018 | 383 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 432 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 738 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 811 | 0.030 |
Why?
| | Speech Intelligibility | 1 | 2014 | 4 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 361 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 948 | 0.030 |
Why?
| | Time | 1 | 2014 | 87 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1075 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2005 | 2162 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2122 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2863 | 0.020 |
Why?
| | Bacteriophage Typing | 1 | 2012 | 1 | 0.020 |
Why?
| | Abattoirs | 1 | 2012 | 2 | 0.020 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 24 | 0.020 |
Why?
| | Minisatellite Repeats | 1 | 2012 | 39 | 0.020 |
Why?
| | Cues | 1 | 2014 | 323 | 0.020 |
Why?
| | Microinjections | 1 | 2011 | 85 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2011 | 135 | 0.020 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 49 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2366 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2011 | 324 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1013 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 415 | 0.020 |
Why?
| | Functional Laterality | 1 | 2010 | 242 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2009 | 111 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 374 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1261 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 910 | 0.020 |
Why?
| | Probability | 1 | 2008 | 307 | 0.020 |
Why?
| | Gestational Age | 1 | 2011 | 952 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 604 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 465 | 0.010 |
Why?
| | Signal Transduction | 1 | 2019 | 5116 | 0.010 |
Why?
| | Fluorouracil | 1 | 2005 | 207 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 327 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2005 | 383 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2007 | 582 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 873 | 0.010 |
Why?
| | Cisplatin | 1 | 2005 | 328 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1043 | 0.010 |
Why?
| | United States | 1 | 2019 | 15298 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3522 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6951 | 0.010 |
Why?
|
|
Gubbels's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|